Wednesday
18.45 - 19.45 CET
Vienna

Improving CV risk management in patients with obesity

Evening Session

John Deanfield (UK)
Welcome and introduction
Erin Bohula (US)
New insights into CV risk in obesity
John Wilding (UK)
Impact of weight loss on CV risk
Stephen Nicholls (Australia)
Future perspectives on treating CVD in patients with obesity
All
Panel discussion and meeting closure
Symposium by:
Novo Nordisk A/S